DK3730136T3 - Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom - Google Patents

Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom Download PDF

Info

Publication number
DK3730136T3
DK3730136T3 DK20163104.1T DK20163104T DK3730136T3 DK 3730136 T3 DK3730136 T3 DK 3730136T3 DK 20163104 T DK20163104 T DK 20163104T DK 3730136 T3 DK3730136 T3 DK 3730136T3
Authority
DK
Denmark
Prior art keywords
ferricitrate
patients
treatment
kidney disease
chronic kidney
Prior art date
Application number
DK20163104.1T
Other languages
Danish (da)
English (en)
Inventor
Enrique Poradosu
Ron Bentsur
Iii James F Oliviero
Original Assignee
Keryx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmaceuticals Inc filed Critical Keryx Biopharmaceuticals Inc
Application granted granted Critical
Publication of DK3730136T3 publication Critical patent/DK3730136T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK20163104.1T 2012-06-21 2013-06-21 Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom DK3730136T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261662565P 2012-06-21 2012-06-21
US201361757229P 2013-01-28 2013-01-28
US201361800618P 2013-03-15 2013-03-15
US201361801050P 2013-03-15 2013-03-15
EP13807102.2A EP2863906B1 (en) 2012-06-21 2013-06-21 Use of ferric citrate in the treatment of chronic kidney disease patients

Publications (1)

Publication Number Publication Date
DK3730136T3 true DK3730136T3 (da) 2024-01-22

Family

ID=49769729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20163104.1T DK3730136T3 (da) 2012-06-21 2013-06-21 Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom

Country Status (19)

Country Link
US (3) US20130345303A1 (https=)
EP (3) EP2863906B1 (https=)
JP (4) JP2015535209A (https=)
KR (2) KR20200103855A (https=)
CN (2) CN113244209A (https=)
AU (2) AU2013278000A1 (https=)
BR (1) BR112014032049A2 (https=)
CA (1) CA2876982A1 (https=)
DK (1) DK3730136T3 (https=)
EA (1) EA201590062A1 (https=)
ES (2) ES2796254T3 (https=)
FR (1) FR25C1043I1 (https=)
HK (1) HK1214503A1 (https=)
IL (1) IL236356A0 (https=)
MX (1) MX2014015615A (https=)
NO (1) NO2025048I1 (https=)
PL (1) PL3730136T3 (https=)
SG (2) SG11201408521WA (https=)
WO (1) WO2013192565A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011011541A1 (en) 2009-07-21 2011-01-27 Henry Trong Le Ferric citrate dosage forms
TWI653043B (zh) * 2012-12-20 2019-03-11 瑞士商伊蘭科動物健康公司 新用途
EP3003327B1 (en) 2013-06-05 2017-08-09 Tricida Inc. Proton-binding polymers for oral administration
EP2856941B1 (en) * 2013-10-01 2020-11-25 Fresenius Medical Care Deutschland GmbH Method and apparatuses for determining a patient's daily loss of iron
EP3747432A1 (en) * 2013-11-04 2020-12-09 Keryx Biopharmaceuticals, Inc. Ferric citrate for reducing cardiac failure in chronic kidney disease patients
WO2015110968A1 (en) * 2014-01-23 2015-07-30 Lupin Limited Pharmaceutical grade ferric citrate and method for its production
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
RS61409B1 (sr) 2014-12-10 2021-03-31 Tricida Inc Polimeri koji vezuju protone za oralnu primenu opis
TW202302083A (zh) * 2015-03-04 2023-01-16 美商凱克斯生物製藥公司 檸檬酸鐵用於治療缺鐵性貧血之用途
CN104688706B (zh) * 2015-04-01 2017-07-14 成都欣捷高新技术开发有限公司 一种高载药量、快速溶出的枸橼酸铁组合物及其制备方法
WO2016162794A1 (en) * 2015-04-08 2016-10-13 Leiutis Pharmaceuticals Pvt Ltd Pharmaceutical compositions of ferric citrate
WO2016162888A1 (en) * 2015-04-09 2016-10-13 Actavis Group Ptc Ehf. Process for preparing pharmaceutical grade ferric citrate
CN109414453B (zh) 2016-05-06 2023-02-17 特里赛达公司 用于治疗酸碱失衡的组合物
WO2019059172A1 (ja) 2017-09-19 2019-03-28 日本たばこ産業株式会社 過多月経患者及び/又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び/又は治療におけるクエン酸第二鉄の使用
CA3080651A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
WO2019236639A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
MX2021004640A (es) 2018-10-29 2021-05-28 Pharmacosmos Holding As Tratamiento de la deficiencia de hierro con carboximaltosa ferrica.
WO2022150623A1 (en) 2021-01-08 2022-07-14 Akebia Therapeutics, Inc. Compounds and composition for the treatment of anemia
EP4347022A1 (en) 2021-05-27 2024-04-10 Keryx Biopharmaceuticals, Inc. Pediatric formulations of ferric citrate
CN115024495B (zh) * 2022-06-27 2024-03-22 北京金康普食品科技有限公司 改善肾病患者钙磷代谢的营养组合物及其应用
WO2025181559A1 (en) * 2024-02-29 2025-09-04 Sloiron, Inc. Methods for determining the amount of encapsulated and free iron in a sample

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1230118A (zh) * 1996-07-19 1999-09-29 日研化学株式会社 高磷血症治疗剂
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
CN1600302A (zh) * 2003-09-22 2005-03-30 宝龄富锦生技股份有限公司 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
CA2619591C (en) 2005-08-18 2020-03-24 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
PT1973549T (pt) * 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
JP2009525277A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 軟組織石灰化の回復、予防、遅延または安定化方法
WO2011011541A1 (en) 2009-07-21 2011-01-27 Henry Trong Le Ferric citrate dosage forms

Also Published As

Publication number Publication date
ES2970050T3 (es) 2024-05-24
EP2863906B1 (en) 2020-03-18
WO2013192565A3 (en) 2015-10-15
CN104884055A (zh) 2015-09-02
EP3730136A1 (en) 2020-10-28
JP2022070945A (ja) 2022-05-13
US20140234416A1 (en) 2014-08-21
CA2876982A1 (en) 2013-12-27
AU2018203205B2 (en) 2020-03-12
US20150079168A1 (en) 2015-03-19
NO2025048I1 (no) 2025-11-06
JP2018138562A (ja) 2018-09-06
ES2796254T3 (es) 2020-11-26
KR102150135B1 (ko) 2020-08-31
WO2013192565A2 (en) 2013-12-27
BR112014032049A2 (pt) 2017-07-25
CN113244209A (zh) 2021-08-13
AU2018203205A1 (en) 2018-05-31
US20130345303A1 (en) 2013-12-26
EP4335436A2 (en) 2024-03-13
IL236356A0 (en) 2015-02-26
FR25C1043I1 (fr) 2026-01-02
EP3730136B1 (en) 2023-12-27
PL3730136T3 (pl) 2024-03-25
JP2015535209A (ja) 2015-12-10
HK1214503A1 (zh) 2016-07-29
SG11201408521WA (en) 2015-01-29
EP2863906A2 (en) 2015-04-29
SG10201805177PA (en) 2018-07-30
HK1210013A1 (en) 2016-04-15
KR20200103855A (ko) 2020-09-02
AU2013278000A1 (en) 2015-01-22
MX2014015615A (es) 2015-03-20
EP4335436A3 (en) 2024-05-15
KR20150036131A (ko) 2015-04-07
EA201590062A1 (ru) 2016-02-29
JP2020100638A (ja) 2020-07-02

Similar Documents

Publication Publication Date Title
DK3730136T3 (da) Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom
IL285843A (en) Ibrutinib for use in the treatment of chronic graft versus host disease
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
IL235512B (en) Phenylbenzamide derivatives for use in treating diseases mediated by aquaporin
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
PL3542798T3 (pl) Aceklidyna do zastosowania w leczeniu starczowzroczności
DK2883104T3 (da) Anvendelse af kontaktlinse ved behandling af en ofthalmologisk lidelse
HRP20181378T1 (hr) Postupci liječenja pedijatrijskih pacijenata deksmedetomidinom
DK3329909T3 (da) Fenfluramin til anvendelse i behandling af dravet syndrom
DK2734126T3 (da) Medicinske anordninger med aftagelige drejelige kæber
EP2869866A4 (en) Catheter pump
EP4379102C0 (en) PATIENT INTERFACE
EP2925382A4 (en) EXTRACORPOREAL AMBULATORY SUPPORT LUNG
EP2830692A4 (en) Patient interface
PL2673237T5 (pl) Zastosowanie krzemianu cyrkonu do leczenia hiperkaliemii
DK2844279T3 (da) Doseringsprogrammer til behandling af pompes sygdom
EP2906208A4 (en) THERAPEUTIC TREATMENT
EP2832398A4 (en) MEDICAL SHUTTER
PT2911716T (pt) Dispositivo de tratamento extracorporal do sangue
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
DK3040336T3 (da) Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
IL247354A0 (en) Treatment of conditions associated with hyperinsulinaemia
HUE046508T2 (hu) Orvepitant krónikus viszketés kezelésére
DK2984184T3 (da) Anvendelse af dnq eller dnq-87 i kombination med en parp1-inhibitor til behandlingen af cancer
LT2958624T (lt) Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas